Our Partners

Duchesnay

Medac GmbH

Read more about Medac GmbH

Saol Therapeutics

Read more about Saol Therapeutics

Duchesnay

Read more about Duchesnay

Servier

Read more about Servier

EffRx

Read more about EffRx

Otsuka

Read more about Otsuka

Correvio

Read more about Correvio

IBSA

Read more about IBSA

Cheplapharm

Read more about Cheplapharm

Mylan

Read more about Mylan

INTAS

Read more about INTAS

Therapeutic Areas and Products

Cardiology

 Tirofiban Premix 250 ml(in combination with heparin)is indicated  for:  patients with unstable angina or non-Q-wave myocardial infarction to prevent cardiac ischemic events; treatment of acute coronary syndrome, including patients who are to be managed medically and those undergoing PTCA or atherectomy

 Vernakalant hydrochloride 20mg/ml is indicated for: Rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults who are hemodynamically stable

Metabolic

alendronate 70mg indicated for :treatment of osteoporosis in postmenopausal women to prevent fractures, including those of the hip and spine (vertebral compression fractures);       Treatment to increase bone mass in men with osteoporosis.

orlistat 120mg is indicated  for :treatment of  obese patients with a body mass index (BMI) greater or equal to 30 kg/m2, or overweight patients (BMI > 28 kg/m2) with associated risk factors

Blood

Phytomenadione (2mg/ml,10mg/ml)is  indicated for  Prophylaxis and treatment of hemorrhagic disease of the newborn

Urokinase (10,000IU, 100,000IU, 250,000IU, 500,000IU)  indicated for :Peripheral arterial thrombosis;     Acute and subacute deep vein thrombosis; Acute diagnostically confirmed pulmonary embolism, in particular when associated with unstable hemodynamic status;     Thrombosed arteriovenous shunt

Gynecology

10mg pyridoxine hydrochloride &10mg doxylamine succinate are indicated  for : the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management.

Urofollitrophin  75 IU is indicated for :the induction of  ovulation in infertile women suffering from hypothalamus or hypophyseal disorders and in spanomenorrhoeic or amenorrhoeic women

Antineoplastics

BMT

Busulfan 60mg/10ml  is indicated  as a conditioning regimen prior to hematopoietic progenitor cell transplantation

Haemato-oncology

Pegaspargase  750 IU/ml( solution for injection/infusion) is indicated for :treatment in  acute lymphoblastic leukaemia (ALL) in paediatric patients from birth to 18 years, and adult patients

Tretinoin 10mg is indicated  for :the induction of remission in acute promyelocytic leukemia

Oncology

Gemcitabine hydrochloride (200mg,500,mg, 1000mg)is  indicated  for advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas ; bladder cancer ; recurrent or metastatic breast cancer; recurrent epithelial ovarian carcinoma

Hydroxycarbamide 500 mg is indicated  for :  chronic myeloid leukaemia (CML); essential thrombocythemia or polycythemia vera

Decarbazine citrate (200mg,500mg,1000mg) is  indicated for : metastatic malignant melanoma ; advanced Hodgkin’s disease

Oxaliplatin is indicated for: stage III (Duke‘s C) colon cancer; metastatic colorectal cancer; metastatic pancreatic adenocarcinoma

Anti inflamatory

Methotrexate (50mg/ml)is indicated  for: severe psoriasis ; severe rheumatoid arthritis; severe, active juvenile idiopathic arthritis; Mild to moderate Crohn’s disease

Immunological agents

Hepatitis b immunoglobulin 312IU/ml is indicated for : the Prevention of hepatitis B recurrence following liver transplantation

Filgrastim (300mcg, 480mcg)is indicated  for: the reduction in the duration of neutropenia

Anti infective

Ganciclovir 500mg  IV is indicated  for : CMV retinitis in immunocompromised patients; the prevention of CMV disease in transplant recipients

Orphan Drugs/Rare Diseases

Tzamal Biopharma manages its orphan-drug activities through Orphan Israel – Orphan Drugs for Rare Diseases Ltd. (a registered company).

Close Menu

To report  side effect, quality complaint and Medical inquiry, involving the company’s products, You may contact us at: Safety@Tzamal-Medical.co.il with contact details for return
Or by phone #: 972-73-7151111 (Ext.7), 972-73-7151107 with the following information: